Evidence map›Paper›PMID 40102545›Full record

ArticleScientific reports2025

Measurement properties of the Polish version of the Cystic Fibrosis Questionnaire Revised 14+ in the adult population.

Dorota Snop-Perkowska, Jakub Świtalski, Jarosław J Fedorowski, Anna Augustynowicz

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dorota Snop-PerkowskaSchool of Public Health, Centre of Postgraduate Medical Education of Warsaw, 01-826, Warsaw, Poland.
Jakub ŚwitalskiDepartment of Health Economics and Medical Law, Faculty of Health Sciences, Medical University of Warsaw, 01-445, Warsaw, Poland. jakub.switalski@wum.edu.pl.
Jarosław J FedorowskiUniversity of Vermont College of Medicine, Burlington, VT, USA.
Anna AugustynowiczSchool of Public Health, Centre of Postgraduate Medical Education of Warsaw, 01-826, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Measuring the quality of life in patients with cystic fibrosis is an important element of the patient care process. Many tools have been created for this measurement among adults. One of them is the Cystic Fibrosis Questionnaire-Revised 14+ (CFQ-R 14+). Its measurement properties have not been comprehensively assessed in the population of Polish adults. The aim of the study is to verify the construct validity, including structural and criterion validity, as well as internal consistency, of the Polish version of the CFQ-R 14+ in the population of adults with cystic fibrosis. We conducted a cross-sectional survey among adults with cystic fibrosis. After preparing the database, we performed a confirmatory factor analysis (CFA) followed by exploratory factor analysis (EFA) using the parallel analysis method principal axis factoring with Oblimin rotation. Intercorrelations of questionnaire factors and the occurrence of relationships among items for the general scale results was checked. We also presented basic descriptive statistics (mean, median, standard deviation, skewness, kurtosis, minimum and maximum values). The analyses included responses from 220 adult patients. CFA results did not show adequate goodness of fit (χ

Indexed as

Cystic FibrosisQuality of LifeAdultCross-Sectional StudiesFactor Analysis, StatisticalFemaleHumansMaleMiddle AgedPolandPsychometricsReproducibility of ResultsSurveys and QuestionnairesYoung AdultAdultCystic fibrosisPolandQuality of lifeSurveys and questionnaires

Identifiers

PMID40102545
PMCPMC11920500

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.